These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17563278)

  • 21. HIV-infection prevention messages for injecting drug users: sources of information and use of mass media--Baltimore, 1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Jul; 40(28):465-9. PubMed ID: 2062300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-infected injection drug users: health care utilization and morbidity.
    Barash ET; Hanson DL; Buskin SE; Teshale E
    J Health Care Poor Underserved; 2007 Aug; 18(3):675-86. PubMed ID: 17675722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-associated behaviors among injecting-drug users--23 Cities, United States, May 2005-February 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(13):329-32. PubMed ID: 19357632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.
    Garfein RS; Golub ET; Greenberg AE; Hagan H; Hanson DL; Hudson SM; Kapadia F; Latka MH; Ouellet LJ; Purcell DW; Strathdee SA; Thiede H;
    AIDS; 2007 Sep; 21(14):1923-32. PubMed ID: 17721100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive and negative consequences of HIV disclosure among seropositive injection drug users.
    Parsons JT; VanOra J; Missildine W; Purcell DW; Gómez CA
    AIDS Educ Prev; 2004 Oct; 16(5):459-75. PubMed ID: 15491957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes.
    Bruneau J; Daniel M; Kestens Y; Zang G; Généreux M
    J Epidemiol Community Health; 2008 Sep; 62(9):804-10. PubMed ID: 18701731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
    Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
    AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injecting drug users: a stigmatised and stigmatising population.
    Simmonds L; Coomber R
    Int J Drug Policy; 2009 Mar; 20(2):121-30. PubMed ID: 17981451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injection drug users' perceptions of drug treatment services and attitudes toward substitution therapy: a qualitative study in three Russian cities.
    Bobrova N; Alcorn R; Rhodes T; Rughnikov I; Neifeld E; Power R
    J Subst Abuse Treat; 2007 Dec; 33(4):373-8. PubMed ID: 17499960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. As HIV spreads among injection drug users, treatment lags behind.
    AIDS Alert; 1998 Oct; 13(10):109-13. PubMed ID: 11365869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Condom use among injection drug users accessing a supervised injecting facility.
    Marshall BD; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
    Sex Transm Infect; 2009 Apr; 85(2):121-6. PubMed ID: 18812391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.
    Golub ET; Purvis LA; Sapun M; Safaeian M; Beyrer C; Vlahov D; Strathdee SA
    AIDS Behav; 2005 Sep; 9(3):301-9. PubMed ID: 16088366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Keeping it together: stigma, response, and perception of risk in relationships between drug injectors and crack smokers, and other community residents.
    Mateu-Gelabert P; Maslow C; Flom PL; Sandoval M; Bolyard M; Friedman SR
    AIDS Care; 2005 Oct; 17(7):802-13. PubMed ID: 16120497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
    Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS
    PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agents of change: peer mentorship as HIV prevention among HIV-positive injection drug users.
    Mackenzie S; Pearson C; Frye V; Gómez CA; Latka MH; Purcell DW; Knowlton AR; Metsch LR; Tobin KE; Valverde EE; Knight KR
    Subst Use Misuse; 2012 Apr; 47(5):522-34. PubMed ID: 22428820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neighborhood social disorder as a determinant of drug injection behaviors: a structural equation modeling approach.
    Latkin CA; Williams CT; Wang J; Curry AD
    Health Psychol; 2005 Jan; 24(1):96-100. PubMed ID: 15631567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV transmission in Bangladesh: an analysis of IDU programme coverage.
    Reddy A; Hoque MM; Kelly R
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S37-46. PubMed ID: 18207724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union.
    Wolfe D
    Int J Drug Policy; 2007 Aug; 18(4):246-54. PubMed ID: 17689372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of social networks in their association to drug equipment sharing among injection drug users: a review.
    De P; Cox J; Boivin JF; Platt RW; Jolly AM
    Addiction; 2007 Nov; 102(11):1730-9. PubMed ID: 17935581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in HIV treatment and prevention: should treatment optimism lead to prevention pessimism?
    Lert F
    AIDS Care; 2000 Dec; 12(6):745-55. PubMed ID: 11177454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.